UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 14, 2022
Accession Number:
0001493152-22-000830
Submission Type:
POS AM
CIK:
0001517681
Company Name:
Propanc Biopharma, Inc.
File Number:
333-238240